Poteligeo Patent Expiration

Large Molecule Patents


Patent Number Company Patent Title Patent Expiry Activity Alert
US7504104 NA Human CDR-grafted antibody and antibody fragment thereof
Jan, 2028

(3 years from now)

Active


Ingredients:

Poteligeo contains Mogamulizumab-kpkc as an active ingredient